Please login to the form below

Not currently logged in
Email:
Password:

WHO and FIP sign joint initiative for TB

The World Health Organisation and the International Pharmaceutical Federation has signed a joint statement to strengthen the role of pharmacists in tuberculosis care and control

The World Health Organisation (WHO) and the International Pharmaceutical Federation (FIP) have signed a joint statement, clarifying the role of pharmacists in tuberculosis (TB) care and control.

The statement, signed at the Federation's 71st International Congress in Hyderabad, India, puts forward a series of measures to help detect TB; offer treatment support; and reduce the number of deaths from the disease.

These measures would be achieved by engaging the FIP's network of pharmacists and pharmaceutical scientists and motivating them to become fully involved in national TB care and control efforts.

The statement calls on TB programmes and pharmacy associations to use their potential to increase awareness, provide patient-centered treatment supervision and refer people to facilities, amongst other suggestions.

Despite TB being one of the world's biggest infectious killers, it can be treated and cured through a six month course of prescribed medicines.

5th September 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics